In an inverse relationship, PDCD4 expression was found to be increased with diminished ovarian cancer differentiation (11), while treatment of human smooth muscle cells with bone morphogenetic protein 4 (BMP-4) and transforming growth factor beta (TGF-β) was found to decrease PDCD4 expression during smooth muscle differentiation (41). The gene discussed is BMP4; the disease is ovarian carcinoma.